276 related articles for article (PubMed ID: 17913302)
61. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
62. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction.
Domico LM; Zeevalk GD; Bernard LP; Cooper KR
Neurotoxicology; 2006 Sep; 27(5):816-25. PubMed ID: 16889834
[TBL] [Abstract][Full Text] [Related]
63. Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors.
Lee JY; Koh HC; Chang MY; Park CH; Lee YS; Lee SH
Neuroreport; 2003 Jul; 14(10):1401-4. PubMed ID: 12876482
[TBL] [Abstract][Full Text] [Related]
64. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons.
Korotkova TM; Ponomarenko AA; Haas HL; Sergeeva OA
Eur J Neurosci; 2005 Sep; 22(6):1287-93. PubMed ID: 16190884
[TBL] [Abstract][Full Text] [Related]
65. VIP is a transcriptional target of Nurr1 in dopaminergic cells.
Luo Y; Henricksen LA; Giuliano RE; Prifti L; Callahan LM; Federoff HJ
Exp Neurol; 2007 Jan; 203(1):221-32. PubMed ID: 16999955
[TBL] [Abstract][Full Text] [Related]
66. Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers.
Yamazoe H; Iwata H
Biomaterials; 2006 Oct; 27(28):4871-80. PubMed ID: 16766027
[TBL] [Abstract][Full Text] [Related]
67. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
68. Cytotoxicity of beta-carbolines in dopamine transporter expressing cells: structure-activity relationships.
Wernicke C; Schott Y; Enzensperger C; Schulze G; Lehmann J; Rommelspacher H
Biochem Pharmacol; 2007 Oct; 74(7):1065-77. PubMed ID: 17692827
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of proteoglycan synthesis affects neuronal outgrowth and astrocytic migration in organotypic cultures of fetal ventral mesencephalon.
Berglöf E; Plantman S; Johansson S; Strömberg I
J Neurosci Res; 2008 Jan; 86(1):84-92. PubMed ID: 17868150
[TBL] [Abstract][Full Text] [Related]
70. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
Lee SY; Moon Y; Hee Choi D; Jin Choi H; Hwang O
Neurobiol Dis; 2007 Jan; 25(1):112-20. PubMed ID: 17049260
[TBL] [Abstract][Full Text] [Related]
71. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
72. Generation and properties of a new human ventral mesencephalic neural stem cell line.
Villa A; Liste I; Courtois ET; Seiz EG; Ramos M; Meyer M; Juliusson B; Kusk P; Martínez-Serrano A
Exp Cell Res; 2009 Jul; 315(11):1860-74. PubMed ID: 19327351
[TBL] [Abstract][Full Text] [Related]
73. Enhanced proliferation and dopaminergic differentiation of ventral mesencephalic precursor cells by synergistic effect of FGF2 and reduced oxygen tension.
Jensen P; Gramsbergen JB; Zimmer J; Widmer HR; Meyer M
Exp Cell Res; 2011 Jul; 317(12):1649-62. PubMed ID: 21570391
[TBL] [Abstract][Full Text] [Related]
74. Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells.
Maciaczyk J; Singec I; Maciaczyk D; Nikkhah G
Exp Neurol; 2008 Oct; 213(2):354-62. PubMed ID: 18652826
[TBL] [Abstract][Full Text] [Related]
75. HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells.
Johansen JL; Sager TN; Lotharius J; Witten L; Mørk A; Egebjerg J; Thirstrup K
J Neurochem; 2010 Oct; 115(1):209-19. PubMed ID: 20649842
[TBL] [Abstract][Full Text] [Related]
76. Dopamine release in organotypic cultures of foetal mouse mesencephalon: effects of depolarizing agents, pargyline, nomifensine, tetrodotoxin and calcium.
Larsen TR; Rossen S; Gramsbergen JB
Eur J Neurosci; 2008 Aug; 28(3):569-76. PubMed ID: 18702728
[TBL] [Abstract][Full Text] [Related]
77. Neuronal PAS domain protein 1 regulates tyrosine hydroxylase level in dopaminergic neurons.
Teh CH; Loh CC; Lam KK; Loo JM; Yan T; Lim TM
J Neurosci Res; 2007 Jun; 85(8):1762-73. PubMed ID: 17457889
[TBL] [Abstract][Full Text] [Related]
78. Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.
McMillan CR; Sharma R; Ottenhof T; Niles LP
Neurosci Lett; 2007 Jun; 419(3):202-6. PubMed ID: 17482356
[TBL] [Abstract][Full Text] [Related]
79. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.
Albéri L; Sgadò P; Simon HH
Development; 2004 Jul; 131(13):3229-36. PubMed ID: 15175251
[TBL] [Abstract][Full Text] [Related]
80. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo.
Pan T; Zhu W; Zhao H; Deng H; Xie W; Jankovic J; Le W
Brain Res; 2008 Jul; 1222():222-9. PubMed ID: 18579122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
